[1]斯晓燕,赵永强.肝素诱导的血小板减少症[J].中华内科杂志,2008,47(1):71-72. [2]高亚玥,赵永强,王书杰.酶联免疫吸附法检测抗肝素/血小板因子4复合物抗体的临床意义[J].中日友好医院学报,2011,25(6):331-337. [3]王京华,车德海,谢蕊,等.Ⅱ型肝素诱导的血小板减少症患者血清HIT抗体检测的临床意义[J].中华血液学杂志,2008,29(9):633-634. [4]ODonnell J.Anticoagulants:therapeutics,risks,and toxicity-special emphasis on heparin-induced thrombocytopenia (HIT) [J].J Pharm Prac,2012,25:22-29. [5]Warkentin TE.Think of HIT[J].Hematology Am Soc Hematol Educ Program,2006:408-414. [6]Cuker A,Gimotty PA,Crowther MA,et al.Predictive value of the 4Ts scoring system for heparin-induced thrombocytopenia:a systematic review and meta-analysis[J].Blood,2012,120(20):4160-4167. [7]Jaax ME,Greinacher A.Management of heparin-induced Thrombocytopenia[J].Expert Opin Pharmacother,2012,13(7):987-1006. [8]叶絮,刘晓力,冯莹,等.蛋白S基因突变导致深静脉血栓形成的研究[J].南方医科大学学报,2011,31(7):1228-1231. |